Monday 10 August 2015

HIV diagnostics Market Size, Segmentation To 2022: Grand View Research, Inc.

HIV, also known as human immune deficiency virus, spreads through sexual contact with an HIV-infected person. It is the virus that causes AIDS, a condition wherein the body losses its immunity towards infectious diseases and succumbs to them. The HIV diagnostics market deals with all such medical instruments and tests that are utilized to detect whether a person has contracted HIV/AIDS. HIV is found in blood and other body fluids. The worldwide market is estimated to expand to about USD 4.5 billion by the end of 2022.


Outlook
The vital component which is responsible for the expansion of the HIV diagnostics market includes rising requirement for the development of more sensitive point of care tests for HIV detection. These tests can be simply adopted at the site of patient care in resource restricted settings. Technological upgradation of tests which is estimated to bring forth various point of care and novel rapid tests during the forecast phase is another prime factor, positively impacting the HIV diagnostics market.
Moreover, governmental programs and crusades against HIV and worldwide medical attempts towards reducing illnesses are likely to serve as future prospects for the market. Huge unmet needs in the Eastern and Middle Eastern regions of the world also act as future growth opportunities for the HIV diagnostics market. The worldwide market was anticipated at around USD 2, 173 million in 2014. It is likely to expand at about 9.5 percent CAGR through the forecast phase.


Rising HIV population, developments in medical technologies and growing awareness regarding HIV/AIDS are the other critical factors that push further development of the HIV diagnostics market. Shortage of medical labs with advanced facilities and scarcity of skilled medical experts capable of performing routine tests are the two main factors which prevent the market from developing further. Augmented need for easily available, fast HIV and effective diagnostics tests is also expected to propel the sales of the HIV diagnostics market.
The anticipated boost in product offerings to the worldwide market is also poised to support the sales of the market. Laboratory restrictions come in the way of the HIV diagnostics market. Intensifying promiscuous behavior involving multiple partners and growing ‘high risk category’ population also amplify the utilization of HIV diagnostics. This factor also drives further demand for the market.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/clinical-diagnostics

Significant Findings
HIV diagnostic tests involving the detection of antibodies to HIV occupied the biggest share in 2014. This big share can be credited to the high infiltration rates of HIV tests, such as Elisa, Rapid, Western Blot in theHIV diagnostics market. These tests are very accurate and sensitive and are utilized for the testing and confirmation of HIV. CD4 and Viral Load Testing also captured significant shares in 2014.
Rising HIV diagnostic products are estimated to further the sales of the HIV diagnostics market.North America held the biggest share in 2014. It leaded the worldwide market. This was in view of supportive repayment policies for HIV and other communicable diseases. The Asian Pacific HIV diagnostics market is projected to augment more rapidlythan the North American region through the forecast phase.

For More Information about site: http://www.ni2014.org/



Diabetic Retinopathy Market Size, Segmentation To 2022: Grand View Research, Inc.

Diabetic retinopathy refers to an eye disorder that injures the retina’s blood vessels. The light-sensitive interior eye surface on which images are produced is known as the retina. Diabetes can impact the retina in the long run. This is owing to high levels of blood glucose injuring the retina’s small blood vessels. The management of diabetic retinopathy relies on the phase of the illness. It is led forward to hinder or prevent the disease from advancing further. Anti-VEGF drugs, laser surgery and vitrectomy are some of the treatments available.


Outlook
Rising diabetes cases around the world are expected to steer further demand for the diabetic retinopathy market. The worldwide market was predicted to have collected an income worth around 5, 934 million in 2014. It is projected to rise at about 6.8 percent CAGR through the forecast phase. Growing blindness cases triggered by diabetes also further the market.


The diabetic retinopathy market includes screening of the retina and choice of treatment based on how severe the condition is.Moreover, augmenting population of the elderly is also estimated to improve the applicability of the market, thus propelling the same. Financialsustainability on account of 11 percent worldwide medical expenses in the management and prevention of this illness is a primary driver for emergent regions to endorse the diabetic retinopathy market.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Categories
The various categories into which the diabetic retinopathy market is divided are treatments, kinds and geographies. The treatments market consists of intraocular steroid injections, anti-VEGF treatment, vitrectomy and laser surgery.
The market, on account of kinds, is segmented into non-proliferative diabetic retinopathy and proliferative diabetic retinopathy. The geographies diabetic retinopathy market is fragmented on the basis of Europe, rest of the world, North America and Asia Pacific.
Leaders
The treatments diabetic retinopathy market is likely to be dominated by the anti-VEGF sector. This sector is predicted to occupy the biggest share through the forecast phase. This is due to connected attributes, such as quicker recuperation and improved treatment. The kinds diabetic retinopathy market was dominated by the sector of non-proliferative diabetic retinopathy in 2014. This sector made up for the biggest share. This was on account of several patients within an illness history of less than ten years.
Growing diabetes cases, non-compliant screening of retina and falling short of exact detection are the drivers of the non-proliferative diabetic retinopathymarket sector. Proliferative diabetic retinopathy is estimated to experience profitable expansion in the future.This expansion is expected owing to the rising population of old people entering the proliferative phase of retinopathy. The geographies diabetic retinopathy market was leaded by North America in 2014. The region occupied the biggest share.
This was due to increasing diabetes cases, rising demand for the untimely diagnosis of diabetic retinopathy and favorable reimbursement amenities. Huge infiltration of anti-VEGF drugs in markets is a prime factor adding revenue to this region. The Europeandiabetic retinopathy market followed North America and produced the second biggest income. It was propelled forward by amplified consciousness among patients. The developing countries of Asia Pacific are anticipated to undergo significant expansion through the forecast phase.
This is because of the intensifying old population, growing disposable incomes and boosting research subsidies for diabetes.

For More Information about site: http://www.ni2014.org/



Tuesday 4 August 2015

Smart Healthcare Market to 2022 – Market Estimate, Industry Size:Grand View Research, Inc.

Medical data systems offer economical and sustainable solutions for the alteration, compilation and processing of medical data and knowledge. Smart medical systems facilitate the simple recovery of health reports and patient histories. They also facilitate accessto history of patients from different geographical regions. Consequently, smart healthcare systems enable doctors and surgeons to treat patients in a better manner. These systems also provide access to significant health records of patients, thereby simplifying and enhancing doctors’ treatment procedures.


Rising demand for private healthcare (with simple data recovery) and track record is one of the important factors, steering the smart healthcare market further. Conversely, the absence of safe information storageand shortage of skilled medical personnel are the prime hindrances for the market. The various consumer sectors of the smart healthcare market are individual patients, hospitals, government medical establishments, research and development establishments and others.
The applications sector of the smart healthcare market includes remote patient monitoring, telemedicine, electronic health records, medical management and others. Rising demand for smart healthcare services across application and consumer sectors is estimated to propel the sales of the smart healthcare market. The market is expected to experience profits during the forecast period. This is on account of increasing technological innovations in the branch of medical information technology.
Moreover, the growth and surfacing of smart pills, syringes and bandages are also estimated to boost the smart healthcare market through the forecast period. Fiscal restrictions with regard to smart healthcare services and low consciousness levels in relation to the growth of above mentioned products also prevent further progress of the smart healthcare market.

Segments
The worldwide market is sliced into two segments. These include products and regions.

Products Insights
The significant products under the smart healthcare market include RFID smart cabinets, mHealth, telemedicine, smart pills, smart syringes, and electronic heath records. Electronic health records were one of the highest income producing segments in 2014. mHealth is anticipated to undergo a CAGR of more than 45 percent during the forecast phase.
The vital factors responsible for this decent CAGR are the various benefits linked with mHealth. Increased occurrence of cardiac ailments, cancer and diabetes are a factor, generating increased revenue for mHealth systems. Fast growth and augmenting buying power has led to the proliferation of smart phones. This is predicted to be a vital factor, positively affecting the mHealth and smart healthcare market.

Regions Overview
The various regions under the smart healthcare market include Europe, rest of the world, North America and Asia Pacific. North America was reportedly the biggest in 2014. The prime factor responsible for its huge share is supportive governmental initiatives. ThemHealth market in the region was estimated at about USD 999 million in 2013.
It is projected to rise at a profitable CAGR during the years ahead. The European smart healthcare market is anticipated to produce the highest income by the end of the forecast period. The Asian Pacific market is likely to boost further in the future. This is on account of supportive governmental initiatives and continually improving medical and infrastructural amenities.

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information about site: http://www.ni2014.org/






Geriatric Care Services Industry to 2022 – Market Outlook, Industry Trends:Grand View Research, Inc.

The increased population of baby boomers in the United States of America is one of the prime components, driving further demand for the geriatric care services market. The market was predicted to have collected an income of about USD 560 billion in 2012. It is estimated to expand at around 6 percent CAGR during 2013 to 2019. This phase marks the forecast period. The geriatric care services market is likely to earn a revenue of around USD 850 billion by the end of the forecast period.


Geriatric care services are inclusive of various individual care, healthcare and helpful services. The services ensure that the requirements of the elderly are met. These elderly have restrictions for self care owing to chronic illnesses, injuries, mental, physical or cognitive disabilities or other health connected problems. The services are also inclusive of aid with daily living activities, like grooming, dressing, bathing, eating, etc. These services assist people in enhancing or upholding the finest living quality and physical functioning.
Rising old population attempting to live on their own and innovations in technologies for geriatric population are also estimated to add income to the geriatric care services market. In addition to these, the growing population of oldest people susceptible to illnesses, like neurological and breathing disorders is also accountable for pushing the market ahead.
Categories And Leaders
The geriatric care services market is segmented in view of two categories. These are services and geographies. The services market includes adult day care, home care, and institutional care. The sector of institutional care occupied the biggest share in 2012. Home care followed institutional care and landed the second spot with respect to income in the geriatric care services market. It is expected to grow further during the forecast period. Institutional care is the most expensive of all care services. It offers quality care services and has been the most technologically advanced and biggest sector.
However, the feeling of being left out by the family among the elderly and high costs of institutional care are estimated to hinder the pace of this sector in the geriatric care services market. Adult day care is also anevolving sector and is estimated to notice further growth in the future. It provides various benefits. Some of these are home living, improved life quality, social communication, refreshment and skillful nursing services. These benefits augur well for the sector and steer it forward. They even promote further growth of the geriatric care services market.
The worldwide geriatric care services marketis also fragmented on account of various regions. These are Europe, rest of the world, Asia Pacific and North America. North America and Europe are anticipated to dominate the geriatric care services market through the forecast period. In urbanized countries, like Canada, the United States, Germany, Spain, France and Italy, the market is experiencing decent expansion. This is on account of the growing elderly population choosing geriatric care services.
Chronic diseases among old people, rising life expectation and restrictions in performing useful and reasoning activities are the other apparent causes for the further development of the geriatric care services market in industrialized countries.

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information about site: http://www.ni2014.org/






Monday 3 August 2015

Personalized Medicine Market to 2022 – Market Estimate, Industry Size:Grand View Research,Inc.

The worldwide personalized medicine market is projected to rise at about 9.5 percent CAGR from 2010 to 2015. This rise is estimated to be steered forward by the untimely detection of diseases and cost reductions on treatments. Additionally, drug safety, therapy optimization and patient conformity are also predicted to drive the market ahead.
Rising technological innovations and advancements in DNA technology are likely to lead towards the formation of the personalized medicine market in France, United Kingdom, China, India and Japan. The worldwide market is anticipated to experience imperative expansion in the years to come. Personalized medicines are powerful customized remedies for individual patients.


Other factors propelling the personalized medicine market forward are increased consciousness regarding health, enhancements in technologies and innovations in the medical sector. The market is also expanding further on account of rising life threatening illnesses, like cancer and AIDS. Moreover, poor lifestyles, escalating consumption of unhealthy food and amplified population of the aged are leading to increasing chronic illnesses.
These illnesses lead towards accessing personalized medicines to take care of the former. This factor also steers the sales of the personalized medicine market.
Categories
The market can be sliced on account of four categories. These include technologies, applications, products and regions. The technologies market can be divided further into point of care, stem cell therapy, pharmacoproteomics, pharmacogenetics, pharmacokinetics, pharmacodynamics and metabolomics.
The applications personalized medicine market can be segmented in view of government, diagnostics, medical and pharmaceuticals. Rising demand for personalized medicines across these sectors is also projected to drive increased demand for the market.
The products personalized medicine market can be segmented, considering PM therapeutics; PM diagnostics; personalized nutrition and wellness; and personalized medical care. The regions market is sliced on the strength of four regions. These are Asia Pacific, rest of the world, North America and Europe.
Escalating demand for personalized medicines across these regions also drives the demand for the personalized medicine market.
Leaders
The technologies market was dominated by pharmacogenomics. Point of care followed pharmacogenomics and occupied the second position. This was with respect to share in the personalized medicine market.
The applications market was leaded by medical. Medical captured majority of the shares. The products personalized medicine market was dominated by personalized nutrition and wellness. Personalized nutrition and wellness captured the biggest share.
High accessibility and large population drive this segment. PM diagnostics and PM therapeutics are predicted to rise most rapidly through the forecast period. This is on account of innovations in the sector of genetic medicine. The regions personalized medicine market was dominated by North America.
High-tech medical infrastructure, supportive governmental policies in relation to research on cancer and rising consciousness levels are the major factors, driving this region. Asia Pacific is anticipated to undergo profitable expansion through the forecast period.
High infiltration of personalized medicines and massive population are responsible for driving this region. Rising joint proposals between eastern and western market members are also estimated to steer the Asian Pacific personalized medicine market ahead.
China and India contribute revenue to this regional market. Presently, they are facing growing demand for personalized medicines.

For More Information about site: http://www.ni2014.org/





Medical oxygen concentrators Market to 2022 – Market Estimate, Industry Size

Medical oxygen concentrators have been one of the most prominentinnovative things in permanent oxygen therapy support. A medical oxygen concentrator is a healthcare instrument operated via electrical means. It is utilized to offer concentrated or refined oxygen to a patient looking for oxygen therapy.
Such an instrument functions on the norm of forcing air into itself which then detaches oxygen and continually supplies it to patients. Medical oxygen concentrators are deemed harmless, simple to utilize and economicalas against compressed oxygen cylinders. These instruments are often advised to patients suffering from chronic pulmonary illnesses.


Market Overview
The medical oxygen concentrators market is steered forward by the ability of oxygen concentrators to supply oxygen under all situations and global ‘growing older’ population. Increased incidences of respiratory illnesses and COPD also push further development of the market. The various benefits linked with these instruments include usage simplicity, less weight and growing affordability. These benefits augur really well for the medical oxygen concentrators market and further it both in terms of size and volume.
The worldwide market is projected to achieve a size of around USD 2 billion by 2020. Growing population of old people with lower body resistance to respiratory illnesses and COPD is also predicted to remain a vital driving factor of the medical oxygen concentrators market. Supportive initiatives of the government in respect to the utilization of portable oxygen concentrators are also anticipated to steer the sales of the market.
COPD alliance in Europe is also estimated to positively affect the medical oxygen concentrators market through the forecast period.

Categories
The various categories into which the medical oxygen concentrators market is divided are products, technologies, applications and geographical regions. The products under the market are fixed medical oxygen concentrators and portable medical oxygen concentrators. The technologies market consists of continuous flow technology and pulse dose technology.
The medical oxygen concentrators market, in view of applications, is segmented on the basis of non-home care services and home care services. The geographies market includes the regions of Asia Pacific, rest of the world, Europe and North America.


Leaders  
The products medical oxygen concentrators market was dominated by portable medical oxygen concentrators in 2014. These concentrators occupied more than 50 percent of the worldwide income. This income was attributed to growing demand for portable and lightweight concentrators at different places. Fixed medical oxygen concentrators are estimated to experience a stable growth of about 10 percent during the forecast period.
The technologies medical oxygen concentrators market noticed high infiltration from pulse dose technology in 2014. This was due to rising incidences of COPD and respiratory illnesses. Continuous flow technology, alternatively, occupied the biggest share.
The applications medical oxygen concentrators market was dominated by home care services in 2014. Home care services captured a share of more than 50 percent. This was owing to rising demand for home healthcare. Non-home care services are mostly utilized in hospitals and healthcare centers.
The geographies market was dominated by North America in 2014. Asia Pacific is the most profitable medical oxygen concentrators market during the forecast phase.

For More Information about site: http://www.ni2014.org/



Sunday 2 August 2015

Power Transformers Market to 2020 – Market Estimate, Industry Size: Grand View Research, Inc.

The global power transformers market is expected to reach USD 18.55 billion by 2020, according to a new study by Grand View Research, Inc. Growing energy demand, on a global level, is expected to be the key driving force for the power transformers market over the next six years. Favorable regulatory scenario for the development of low noise and environmentally friendly transformers is also expected to drive the market over the forecast period.

Browse full research report on Global Power Transformers Market: http://www.grandviewresearch.com/industry-analysis/power-transformers-market

Increasing investment in power plant infrastructure in developing markets of Asia Pacific is expected to boost regional demand. The market in North America and Europe is expected to primarily be driven by need for replacing aging equipment. Smart grid and super grid development initiatives are expected to be a considerable opportunity for market participants. Volatility in prices of key raw materials such as steel and copper is expected to be a barrier for industry growth.

Read detailed report or request for sample of this research report:
http://www.grandviewresearch.com/industry-analysis/power-transformers-market

Further key findings from the study suggest:
  • Global power transformers shipments were estimated to be 11,352 units in 2013, and are expected to reach 16,994 units by 2020, growing at a CAGR of 5.9% from 2014 to 2020.
  • Power transformers with a rating of 100 MVA to 500 MVA are expected to continue dominating global demand, and accounted for over 73% of the overall market volume in 2013. It is also expected to be the fastest growing segment, at an estimated CAGR of 6.4% in terms of revenue from 2014 to 2020.
  • Asia Pacific accounted for over 40% of the market in 2013; it is also expected to grow at the fastest CAGR of 6.6% in terms of revenue from 2014 to 2020. Growing population as well as increasing demand for electricity is expected to fuel the market in this region over the forecast period.
  • Companies operating in the market include ABB Ltd., Alstom SA, General Electric, Siemens Energy and Toshiba Corp. among others. New product development and innovation in order to meet regulatory requirements and address growing demand are among the key strategies employed for market expansion.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/construction-and-utilities

For the purpose of this study, Grand View Research has segmented the global power transformers market on the basis of product and region:
    • Power Transformers Product Outlook (Volume, Unit Shipments and Revenue, USD Billion; 2012 - 2020)
            • 100 MVA to 500 MVA
            • 501 MVA to 800 MVA
            • 801 MVA to 1200 MVA
    • Power Transformers Regional Outlook (Volume, Unit Shipments and Revenue, USD Billion; 2012 - 2020)
            • North America
            • Europe
            • Asia Pacific
            • RoW

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc



Biotechnology Market Share, Analysis, Trends To 2020 by Grand View Research, Inc.

The global market for biotechnology is expected to reach USD 604.40 billion by 2020, according to a new study by Grand View Research, Inc. Increasing application scope coupled with the rising demand for effective vaccines and drugs in an attempt to improve healthcare access to patients with unmet medical needs is expected to drive market demand over the next six years. In addition, the need to enhance agricultural productivity via the use of genetically engineered seeds is expected to serve this market as a driver.

Browse full research report on Global biotechnology Market: http://www.grandviewresearch.com/industry-analysis/biotechnology-market

Biopharmacy dominated the overall market, accounting for over 60% of the total revenue in 2013. High costs associated with the drug discovery process coupled with increasing healthcare expenditures in emerging markets such as India, China and Brazil are some of the factors augmenting biopahrmacy growth. Growing popularity of contract research outsourcing (CRO) services in an attempt to curb manufacturing and R&D costs are expected to drive bioservices demand, which is expected to be the fastest growing application market for biotechnology.

Read detailed report or request for sample of this research report:
http://www.grandviewresearch.com/industry-analysis/biotechnology-market

Further key findings from the study suggest:
  • North America was the largest regional market, accounting for over 40% of global revenue in 2013, with growth being driven by the presence of sophisticated healthcare infrastructure, high patient awareness levels and healthcare expenditure.
  • Asia Pacific is expected to register the fastest CAGR of 14.8% during the forecast period owing to the presence of untapped opportunities in emerging markets such as India and China.
  • Tissue engineering and regeneration technology dominated the market in terms of revenue share in 2013 at 32.5% on account of the rising demand for regenerative medicine.
  • Key industry participants include Novo Nordisk, Amgen, Gilead Sciences, Celgene, Biogen Idic, Teva Pharmaceutical Industries, Merck KGaA, CSL, Regeneron, Alexion Pharmaceuticals, Shire PLC, Vertex Pharmaceuticals, BioMarin Pharmaceutical, Elan, Actelion, Onyx Pharmaceuticals, Dr. Reddy’s Laboratories, Seattle Genetics, Alkermes, Ariad Pharmaceuticals, Cubist Pharmaceuticals, United Therapeutics, Ipsen Group and DiaSorin.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology

For the purpose of this study, Grand View Research has segmented the global biotechnology market on the basis of application and region:
    • Biotechnology Application Outlook
            • Medical Gases
            • BioPharmacy
            • BioServices
            • BioAgriculture
            • BioIndustrial
    • Biotechnology Technology Outlook
            • Fermentation
            • Tissue engineering and Regeneration
            • PCR Tehnology
            • Nanobiotechnology
            • Chromatography Market
            • DNA Sequencing
            • Cell Based Assay
            • Others
    • Biotechnology Regional Outlook
            • North America
            • Europe
            • Asia Pacific
            • RoW

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc



Wednesday 29 July 2015

Medical Gases Market To 2020- Industry Trends, Forecast: Grand View Research, Inc.

The global market for medical gases and equipment is expected to reach USD 10.52 billion by 2020, according to a new study by Grand View Research, Inc. The implementation of industry friendly regulations such as the FDA Safety and Innovation Act in the U.S. and growing patient awareness levels are expected to drive market growth over the next six years. Growing global geriatric population base coupled with increasing prevalence of target diseases such as chronic obstructive pulmonary diseases (COPD) is also expected to enhance market demand over the forecast period.

Browse full research report on Global Medical Gases Market: http://www.grandviewresearch.com/industry-analysis/medical-gases-market

Oxygen dominated the global medical pure gases market in 2013, accounting for over 44% of total revenue. Rising prevalence of patients admitted in emergency care and prevalence of patients suffering from respiratory diseases requiring the administration of oxygen are some of the factors accounting for its large market share. Nitrous oxide followed oxygen in terms of market share, accounting for over 25%. However, its market share is expected to decline by 2020, owing to the rising demand for anesthetic drugs. In addition, the medical gas mixtures market was dominated by oxygen-carbon dioxide medical gas mixtures in 2013, accounting for over 30% of revenue.

Read detailed report or request for sample of this research report:
http://www.grandviewresearch.com/industry-analysis/medical-gases-market

Further key findings from the study suggest:
  • North America dominated the overall market in 2013 with revenue estimated at USD 2.48 billion. However, Asia Pacific is expected to be the fastest growing regional market, on account of rapidly developing economies of China and India, at an estimated CAGR of 9.9% during the forecast period.
  • Vacuum systems dominated the overall equipment market in 2013, accounting for over 30% of total revenue, primarily due to the high prices associated with these products.
  • Ethylene oxide segment is expected to be the fastest growing medical gas, at an estimated CAGR of 19.2% from 2014 to 2020. Ethylene oxide is expected to serve as an internal substitute to oxyfume 2000 and cater to the market of the latter post its phasing out by January, 2015.
  • Key industry participants include Linde Gas, Matheson Tri-Gas Inc., Air Products and Chemicals Inc., Air Liquide and Praxair Inc.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

 For the purpose of this study, Grand View Research has segmented the global medical gases and equipment market on the basis of product and region:
    • Medical Gases and Equipment Product Outlook
            • Medical Gases
                    • Medical Pure Gases
                            • Medical Air
                            • Carbon Dioxide
                            • Oxygen
                            • Nitrogen
                            • Nitrous Oxide
                            • Helium
                    • Medical Gas Mixtures
                            • Carbon Dioxide – Oxygen Mixtures
                            • Oxygen-Nitrous Oxide Mixtures
                            • Ethylene Oxide
                            • Oxyfume 2000
                            • Helium Oxygen Mixtures
                            • Aerobic Mixtures
                            • Anaerobic Mixtures
                            • Blood Gas Mixtures
                            • Laser Gas Mixtures
                            • Lung Mixtures
            • Medical Gas Equipment
                    • Manifolds
                    • Outlets
                    • Hose Assemblies and Valves
                    • Alarm Systems
                    • Cylinders and Accessories
                    • Flowmeters
                    • Regulators
                    • Medical Air Compressors
                    • Vacuum Systems
                    • Masks
    • Medical Gases and Equipment Regional Outlook
            • North America
            • Europe
            • Asia Pacific
            • RoW

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc


Monday 27 July 2015

Tissue Engineering and Regeneration Market Size, Segmentation To 2020

A new tissue engineering technique coupled with special mechanisms has given rise to a new form of bio-engineering which may one day generate new organs.
BioP3, a new device created by scientists at the Brown University holds immense potential in tissue engineering. It can already generate new tissues and scientists at the University are hopeful that it will play a defining role in creating organs as well.


Currently 3D printing of organs is seen as one way of achieving sustenance for organ replacement in the future. However, the technology used in BioP3 could give 3D printing in bio-engineering a good run.
The device is currently manually operated by the scientists given the early nature of the invention.
The idea behind the technology is stacking up of tissue pieces one over another. The tissue pieces here are known as “micro-tissues” and are created using a technique called “micro-moulding”. This technique was also developed by the same scientists at Brown as part of the larger process.
Using micro-moulding, cells can be made to take any shape as directed. These individual pieces, or micro-tissues, are then stacked one over the other using a suction nozzle. After a “short time”, these tissues bind together to form the larger composition in the form of an organ.
However, given the lack of automation in this new system, it takes over an hour to stack merely a handful of micro-tissues. The resultant formation is much smaller than what a full-sized organ would be like.
On a brighter note, the group recently received about 1.4 Million in funding and with sustained development, this technology could compete with the currently propagated plan of using bio-printing to make organs which takes tediously long time.
What started as merely tissue engineering could soon lead to faster generation of body organs.


For More Information about site: http://www.ni2014.org/

Sleep Apnea Devices Market Growth, Industry Trends To 2020

Problems with sleeping are quite common and are also referred to as a worldwide epidemic. Sleep apnea is one such problem. Obstructive sleep apnea is very prevalent. About eighty four percent of those afflicted with sleep apnea are detected with obstructive sleep apnea. Research has shown that there are around hundred million obstructive sleep apnea cases in the world and eighty percent out of them remains undetected.
The sleep apnea devices market is new and is achieving momentum with time. This momentum is taking place at a quick rate, particularly in urbanized geographical regions. The sleep apnea devices market demand is predicted to augment at a quicker rate. This is owing to growing consciousness among patients and doctors about this illness.


The market is experiencing extraordinary development across the globe owing to massive need for advanced methodologies of treatment. It is necessary for people to sleep well in order to make sure that they remain healthy. The rapid expansion of the medical devicesindustry is considered to be a major component, driving demand for the sleep apnea devices market.
The sleep apnea devices market was found worth about USD 3, 805 million in 2012. It is estimated to increase from 2013 to 2019, at about 8 percent CAGR. The quick innovations in technology and growing consciousness regarding sleep apnea are anticipated to offer huge prospects of improvement to the market. The sleep apnea devices market is expected to witness maximum development over the projected period.
Not agreeing to resort to these devices for treatment, heavy uneasiness and consistency of remedial devices are expected to prevent the approval of sleep apnea devices. This is likely to prevent the sleep apnea devices market from growing further. North America occupied the biggest share in the market in 2012. It was trailed by Europe in the same year. Both these continents accounted for the lion’s share in the sleep apnea devices market.
This is owing to growing sleep apnea cases, rising awareness about them and increasing acceptance of sleep apnea devices.


For More Information about site: http://www.ni2014.org/

Metal Cans Market Industry to 2020 – Market Outlook, Industry Trends

The medical gas equipment market has huge potential for further growth. This is owing to escalating population of the aged. Consequential augmentation in chronic breathing illnesses and innovations in pharmaceuticals also drive the market. However, periodically altering regulatory concerns with respect to medical gas policies result in high costs. These concerns appear to prevent the medical gas equipment market from growing further.


Apart from structural drivers the market has, there are some geographic components also which drive it forward. Rising economies are gradually getting more attractive. The region of Asia Pacific is a highly capable medical gas equipment market. Budding nations, like China and India have high CAGR figures and are anticipated to witness imperative market development. This owes to increase in respiratory diseases and augmentation in medical infrastructure and per capita returns.
The medical gas equipment market has witnessed a standard shift in the use of technologically developed and enhanced products. This has led to growth in the market. The market has even witnessed widespread development in the last few years. Worldwide scarcity of helium hinders market growth to a certain extent. The market is fragmented on the basis of applications, products and geographical regions. It is estimated to rise during the predicted phase, at about 7 to 8 percent CAGR.
Growing population and rising chronic diseases also drive the medical gas equipment market. Additionally, boost in health consciousness among people, supported by increased medical investments in developing nations is expected to add revenue to the market. North America leaded the market in 2012. It is expected to remain likewise till 2018. 2013 to 2018 remains the predicted phase. North America occupies share worth 40 – 45 percent in the worldwide medical gas equipment market.
Increasing demand for permanent medical services in the coming years is expected to remain the biggest propeller of the North American market. The medical gas equipment market of Europe follows the former and accounts for around 33 percent of the share.


For More Information about site: http://www.ni2014.org/

Friday 24 July 2015

Pancreatic Cancer Materials Industry to 2020– Market Outlook, Industry Trends

The pancreatic cancer treatment market has witnessed considerable growth over the past. It is also likely to grow at around 25.3 percent CAGR by the end of 2017. This is due to rising aged population, developments in technology and government expenditures on cancer treatment.


The United States has the largest number of pancreatic patients globally. Pancreatic cancer is common in men and women between ages of more than 60. Changing lifestyles, obesity, smoking, alcohol consumption and old age are the factors which propel further demand for the pancreatic cancer treatment market. Pancreatic cancer treatments often give insufficient results and may serve as a barrier for the market.
Pancreatic cancer patients are generally diagnosed at an advanced stage. Thus pancreatic cancer treatment market technology for timely diagnosis needs to be developed. Pancreatic cancer has five stages, out of which stage 1 and stage 2 can be cured surgically. Some of the common imaging methods are MRI, ultrasound and CT scan. ERCP (Endoscopic retrograde cholangiopancreatography) is an advanced procedure for diagnosing pancreatic cancer.
The pancreatic cancer treatment market can be segmented on account of whether the cancer affects exocrine or endocrine functions. Adenocarcinoma is the most common exocrine pancreatic cancer. Adenosquamous carcinoma, giant cell carcinoma and squamous cell carcinoma are the other types of endocrine pancreatic cancers.
The United States has shown huge growth for the pancreatic cancer treatment market. It is likely to register USD 1.18 billion by the end of 2017. It would be followed by five European nations. These nations are estimated to have a collective market worth around USD 463 million by 2017. This is due to rising aged population and changing lifestyles in these regions.

For More Information about site: http://www.ni2014.org/






Disposable Syringes Industry Trends, Analysis To 2022

The disposable syringes market is predicted to witness exponential growth over the forecast period. This is due to rising diabetes cases and growing concerns regarding infectious diseases. Disposable syringes are primarily used by physicians for monitoring and diagnosing patients at homes or clinics.


Disposable syringes have outstanding properties over non disposable ones. These are safety, reasonable rates, usage ease and hygiene. These features of disposable syringes are responsible for driving the market over the forecast period. Other factors propelling this market are development in pharmaceuticals and rising concerns about infections, such as hepatitis and HIV.
The disposable syringes market can be segregated into products, consumers, and geographies. The market, on the basis of products, can be divided into insulin injector pens, vaccination injectors, prefilled syringes, hypodermic needles and syringes, safety syringes, blood collection needles, specialty needles and needleless injectors.
The disposable syringes market can be fragmented on the basis of consumers, such as diagnostics laboratories, hospitals, nursing homes, physician clinics and patients. Geographically, the disposable syringes market can be divided into regions of North America, Europe, Asia Pacific and ROW (rest of the world).
Presently, North America is leading the disposable syringes market as a result of huge investments on research and development, technological improvements and patient awareness. The emerging markets of Asia Pacific, including China and India are likely to witness huge growth for the disposable syringes market. This is on account of increasing R&D activities and increasing healthcare expenditures.
Europe is a flourishing market and is likely to witness significant growth over the forecast period. Growing healthcare infrastructure and innovations in medical sector are also predicted to propel the disposable syringes market further.

For More Information about site: http://www.ni2014.org/





Tuesday 21 July 2015

Global X-ray and CT scan Market Trends, Growth Prospects To 2020: Grand View Research, Inc

The global portable X-ray and CT scan market devices is expected to reach USD 8,408.0 million by 2020, according to a new study by Grand View Research, Inc. Rising demand for bedside imaging, home healthcare and the growing use of CT scan devices for anatomical confirmation and to assess the accuracy of medical implants during and post interventional medical procedures are two of the most significant growth drivers of this market.

 Browse full research report on Global Portable X-ray and CT scan Market: http://www.grandviewresearch.com/industry-analysis/portable-x-ray-and-ct-scan-devices-industry

The market will also be driven by factors such as rising prevalence of target diseases such as cardiovascular, dental and orthopedic disorders and cancer, growing global base of geriatric population and the consequent rise in the number of medical procedures especially the ones involving medical implants.
The presence of high growth opportunities in emerging Asian and Latin American countries and the introduction of technologically advanced and cost effective products catering to the cost sensitive clientele present in the aforementioned regions will fuel the future growth of this market. Moreover, the implementation of government initiatives such as the 12th Five Year Plan in China will ease the entrance of market players into these regions and capitalize on the untapped growth opportunities.
The global portable X-ray devices market was dominated by the mobile X-ray devices market on account of the rising demand for bedside imaging and point of care diagnostics. In addition, the fact that these devices eliminate the need for multiple radiology departments in a healthcare institution and therefore prove to be cost effective serves this market as a driver. However, high maneuverability associated with handheld X-ray devices and the introduction of products such as the NOMAD Pro will help the global handheld X-ray devices market exhibit the highest CAGR during the forecast period.

Read detailed report or request for sample of this research report:
http://www.grandviewresearch.com/industry-analysis/portable-x-ray-and-ct-scan-devices-industry

Further Key findings from the study suggest:
  • The global portable X-ray and CT scan devices market was valued at USD 4,677.0 million in 2012 and is expected to grow at a CAGR of 7.6% from 2013 to 2020
  • The global portable CT scan devices market was dominated by the medium slice scanners (64 slices) market owing to their high usage rates and high image resolution capabilities. Its market share was calculated at above 60% in 2012.
  • Digital radiography (DR) is identified as the fastest growing technology in the overall portable X-ray devices market. Rising demand of PACS (Picture Archiving and Communication Systems) based radiology devices and growing demand for filmless X-ray devices are some of the factors accounting for the aforementioned inference. 
North America is expected to dominate the overall market throughout the forecast period owing to the presence of sophisticated healthcare infrastructure, reimbursement framework and high healthcare expenditures in this region. However, the presence of high unmet medical needs in emerging Asian economies such as India and China will help the Asia-Pacific portable X-ray and CT scan devices market grow at the highest CAGR (10.2% from 2013 to 2020).The portable X-ray and CT scan devices market is highly competitive with players such as GE Healthcare, Philips Healthcare, Siemens Healthcare, Hitachi Medical Systems and Varian Medical Systems dominating the market. However, technological innovations play an integral role in the market and manufacturers are developing strategies in congruence with this to ensure sustainability and gain market share. E.g. The launch of handheld X-ray device – “NOMAD Pro” by Aribex Inc.

 Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/healthcare

 For the purpose of this study, Grand View Research has segmented the global portable X-ray and CT scan devices market on the basis of product, technology and region:

Portable X-ray and CT Scan Devices Product Outlook
  • X-Ray Devices
  • Mobile X-Ray Devices
  • Handheld X-Ray Devices
  • CT Scan Devices
Portable X-ray and CT Scan Devices Technology Outlook
  • X-Ray Devices
  • Analog
  • Computed Radiography
  • Digital Radiography
  • CT Scan Devices
  • Low Slice Scanners
  • Medium Slice Scanners
  • High Slice Scanners
Portable X-ray and CT Scan Devices Regional Outlook
  • North America
  • Europe
  • Asia-Pacific
  • RoW
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc


Incontinence and ostomy care productsIndustry to 2020 – Market Outlook, Industry Trends: Grand View Research, Inc.

The global Incontinence and ostomy care products market for is expected to reach USD 17,184.2 million by 2020, according to a new research report by Grand View Research, Inc. The presence of high prevalence rates of incontinence, inflammatory bowel diseases and ulcerative colitis and the rising patient awareness levels are two of the highest impact rendering drivers of this market. Some of the other market drivers include rising demand for home healthcare and institutional care. Rising global geriatric population base and the presence of high growth opportunities in the Asia-Pacific region in terms of unmet medical needs are expected to fuel the future growth of this market.

Browse full research report on Global Incontinence and ostomy care products Market: http://www.grandviewresearch.com/industry-analysis/incontinence-and-ostomy-care-products-industry

Absorbent products dominated the incontinence care products market on account of their high usage rates, accounting for over 85% of market revenue in 2012. Furthermore, the advent of technologically advanced products such as continent ileostomy and continent urostomy bags will help the ostomy care products market grow at an accelerated rate and gain market share during the course of the forecast period.
High prevalence of target disease segments coupled with high patient awareness levels and high per capita healthcare expenditure helped the North American market hold the largest market share of over 35% in 2012. However, high growth opportunities available in rapidly growing economies with large target population bases will help the Asia-Pacific incontinence and ostomy care products market grow at the fastest rate.

Read detailed report or request for sample of this research report:
 
http://www.grandviewresearch.com/industry-analysis/incontinence-and-ostomy-care-products-industry

Further Key findings from the study suggest:
  • The global incontinence and ostomy care products market was valued at USD 11,500.0 million in 2012 and is expected to grow at a CAGR of 5.2% from 2013 to 2020
  • The incontinence care products market held majority of the market share in 2012 and is expected to maintain its market position throughout the forecast period. In addition, this market will grow at the fastest rate during the forecast period. High usage rates of disposable absorbents in developed economies such as the U.S. and Japan and growing acceptance of these products in emerging economies with high unmet needs such as China and India account for its high growth rate.
  • On account of the presence of a large base of patients with unmet incontinence needs, the Asia-Pacific market will grow at the fastest pace. This market is expected to grow at a CAGR of 7.6% from 2013 to 2020.
  • The global incontinence care products market is highly fragmented owing to the presence of a large number of local manufacturers. Some of the prominent market players include SCA (Svenska Cellulosa Aktiebolaget), Kimberly-Clark, Unicharm Corporation and Hartmann.
Some of the key players of the global ostomy care products market include Coloplast, ConvaTec, Hollister Inc., B. Braun Melsungen AG, Salts Healthcare and Eakin Pelican and others

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

For the purpose of this study, Grand View Research has segmented the global incontinence and ostomy care products market on the basis of product and region:
 Incontinence and Ostomy Care Product Outlook
  • Incontinence care
  • Absorbents
  • Incontinence bags
  • Others (clamps, cleaners, deodorizers, urinals)
  • Ostomy care
  • Ostomy bags
  • Colostomy Bags
  • Ileostomy Bags
  • Urostomy Bags
  • Continent ileostomy Bags
  • Continent Urostomy Bags
  • Deodorants
  • Skin barriers
  • Irrigation products
Incontinence and Ostomy Care Regional Outlook
  • North America 
  • Europe 
  • Asia-Pacific
  • Row
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc